Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver

The interaction between amiodarone and digoxin has been known to increase serum concentrations of digoxin in humans and rats. In this study, we assessed the molecular mechanism(s) of that drug interaction, focusing on digoxin transport mediated by P-glycoprotein (Pgp) and by rat liver organic anion...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical research Vol. 19; no. 6; pp. 738 - 743
Main Authors KODAWARA, Takaaki, MASUDA, Satohiro, WAKASUGI, Hiroko, UWAI, Yuichi, FUTAMI, Takahiro, SAITO, Hideyuki, ABE, Takaaki, INUI, Ken-Ichi
Format Journal Article
LanguageEnglish
Published New York, NY Springer 01.06.2002
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The interaction between amiodarone and digoxin has been known to increase serum concentrations of digoxin in humans and rats. In this study, we assessed the molecular mechanism(s) of that drug interaction, focusing on digoxin transport mediated by P-glycoprotein (Pgp) and by rat liver organic anion transporter (oatp2). Digoxin transport by Pgp and oatp2 was assessed using Pgp-overexpressing transfectant LLC-GA5-COL150 monolayers and oatp2-expressing Xenopus oocytes, respectively. The digoxin uptake into the isolated rat hepatocytes was also examined. Amiodarone (10 microM) inhibited slightly the transcellular transport of digoxin in LLC-GA5-COL150 monolayers, whereas itraconazole (10 microM), a potent Pgp inhibitor, markedly blocked the transport. The digoxin uptake by the isolated rat hepatocytes and by the oatp2-expressing Xenopus oocytes was decreased markedly in the presence of amiodarone but not in the presence of itraconazole. In addition, amiodarone inhibited the oatp2-mediated digoxin uptake in a competitive manner with an apparent inhibition constant value of 1.8 microM. These findings suggest that rat oatp2 rather than Pgp may be one of the interaction sites for digoxin and amiodarone in the liver.
ISSN:0724-8741
1573-904X
DOI:10.1023/A:1016184211491